HHS Relaxes Proposed Common Rule Restrictions on Biospecimen Research

Drug Industry Daily
A A
HHS backed down from implementing its more controversial provisions in a broad overhaul of its Common Rule, including requiring researchers to obtain written consent before testing a donor’s biospecimens, even if the samples were presented with no personally identifying information.

To View This Article:

Login

Subscribe To Drug Industry Daily